Systemic autoimmune rheumatic disease prevalence in Canada: Updated analyses across 7 provinces

Journal of Rheumatology

Volumn 41, Issue 4, 2014, Pages 673-679

  Broten, Laurel ^a   Aviña Zubieta, J Antonio ^b   Lacaille, Diane ^b   Joseph, Lawrence ^c   Hanly, John G ^d   Lix, Lisa ^e   O'Donnell, Siobhan ^g   Barnabe, Cheryl ^h   Fortin, Paul R ⁱ   Hudson, Marie ^c   Jean, Sonia ^j   Peschken, Christine ^e   Edworthy, Steven M ^h   Svenson, Larry ^k   Pineau, Christian A ^l   Clarke, Ann E ^a,l   Smith, Mark ^f   Bélisle, Patrick ^a   Badley, Elizabeth M ⁿ   Bergeron, Louise ^m   Bernatsky, Sasha ^a   more..

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ LAVAL UNIVERSITY   (Canada)

^j National Institute of Public Health of Quebec   (Canada)

^k Health Surveillance Branch   (Canada)

^l RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^m Chronic Disease Surveillance Division National Institute of Public Health of Québec ^*  (Canada)

ⁿ UNIVERSITY HEALTH NETWORK   (Canada)

more..

Author keywords

Autoimmune diseases; Prevalence; Rheumatic diseases systemic sclerosis; Systemic lupus erythematosus

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TREND STUDY; URBAN RURAL DIFFERENCE; AGED; AUTOIMMUNE DISEASES; BAYES THEOREM; COMORBIDITY; COMPARATIVE STUDY; EPIDEMIOLOGY; FACTUAL DATABASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RHEUMATIC DISEASES; RURAL POPULATION; SCLERODERMA, SYSTEMIC; SEX RATIO; SJOGREN'S SYNDROME; URBAN POPULATION;

ADULT; AGE DISTRIBUTION; AGED; AUTOIMMUNE DISEASES; BAYES THEOREM; CANADA; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; RHEUMATIC DISEASES; RURAL POPULATION; SCLERODERMA, SYSTEMIC; SEX DISTRIBUTION; SJOGREN'S SYNDROME; URBAN POPULATION;

EID: 84897378422     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130667     Document Type: Article

References (36)

1. Callaghan R, Prabu A, Allan RB, Clarke AE, Sutcliffe N, Pierre YS, et al. Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome. Rheumatology 2007;46:105-11.
2. Bernatsky S, Hudson M, Panopalis P, Clarke AE, Pope J, LeClercq S, et al. The cost of systemic sclerosis. Arthritis Rheum 2009;61:119-23.
3. Aghdassi E, Zhang W, St-Pierre Y, Clarke AE, Morrison S, Peeva V, et al. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis. J Rheumatol 2011;38:658-66.
4. Panopalis P, Petri M, Manzi S, Isenberg DA, Gordon C, Senecal J-L, et al. The systemic lupus erythematosus tri-nation study: cumulative indirect costs. Arthritis Rheum 2007;57:64-70.
5. Hanly JG; Canadian Council of Academic Rheumatologists. Manpower in Canadian academic rheumatology units: current status and future trends. J Rheumatol 2001;28:1944-51.
6. Bernatsky S, Lix L, Hanly JG, Hudson M, Badley E, Peschken C, et al. Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol Int 2011;31:549-54.
7. Centers for Disease Control and Prevention. International Classification of Diseases, 10th revision, Clinical Modification (ICD-10-CM). [Internet. Accessed February 20, 2014.] Available from: www.cdc.gov/nchs/icd/icd10cm.htm
8. Bernatsky S, Joseph L, Pineau CA, Belisle P, Boivin JF, Banerjee D, et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 2008;68:1192-6.
9. Joseph L, Gyorkos TW, Coupal L. Bayesian-estimation of disease prevalence and the paramaters of diagnostic-tests in the absence of a gold standard. Am J Epidemiol 1995;141:263-72.
10. Ashby D. Bayesian statistics in medicine: a 25 year review. Stat Med 2006;25:3589-631.
11. Dendukuri N, Joseph L. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics 2001;57:158-67.
12. Vacek PM. The effect of conditional dependence on the evaluation of diagnostic-tests. Biometrics 1985;41:959-68.
13. Losina E, Barrett J, Baron JA, Katz JN. Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol 2003;56:515-9.
14. Bernatsky S, Joseph L, Pineau CA, Tamblyn R, Feldman DE, Clarke AE. A population-based assessment of systemic lupus erythematosus incidence and prevalence results and implications of using administrative data for epidemiological studies. Rheumatology 2007;46:1814-8.
15. Bernatsky S, Joseph L, Belisle P, Boivin JF, Rajan R, Moore A, et al. Bayesian modelling of imperfect ascertainment methods in cancer studies. Stat Med 2005;24:2365-79.
16. Ladouceur M, Rahme E, Pineau CA, Joseph L. Robustness of prevalence estimates derived from misclassified data from administrative databases. Biometrics 2007;63:272-9.
17. Statistics Canada. Geographic units: Census Metropolitan Area (CMA) and Census Agglomeration (CA). 2002. [Internet. Accessed February 20, 2014.] Available from: www12.statcan.ca/English/census01/Products/Reference/dict/ geo009.htm
18. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum 2008;58:15-25.
19. Kabasakal Y, Kitapcioglu G, Turk T, Oder G, Durusoy R, Mete N, et al. The prevalence of Sjogren's syndrome in adult women. Scand J Rheumatol 2006;35:379-83.
20. Rourke J. In search of a definition of "rural". Can J Rural Med 1997;2:113-7.
21. Statistics Canada. Aboriginal identity population by province and territory (2006 Census). [Internet. Accessed February 20, 2014.] Available from: www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo60a-eng.htm
22. Lindsay C. The Chinese community in Canada. [Internet. Accessed February 11, 2014.] Available from: www.statcan.gc.ca/pub/89-621-x/89-621-x2006001-eng. pdf
23. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994;53:675-80.
24. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991;50:490-2.
25. Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 2010; 6:468-76.
26. Statistics Canada. Age and sex structure: Canada, provinces and territories. [Internet. Accessed February 20, 2014.] Available from: www.statcan.gc.ca/pub/91-215-x/2012000/part-partie2-eng.htm
27. Ng R, Bernatsky S, Rahme E. Observation period effects on estimation of systemic lupus erythematosus incidence and prevalence in Quebec. J Rheumatol 2013;40:1334-6.
28. Canadian Medical Association. Physicians by province/territory and specialty, Canada. 2012. [Internet. Accessed February 20, 2014.] Available from: www.cma.ca/multimedia/CMA/Content-Images/Inside-cma/Statistics/01Spec&Prov. pdf
29. Canadian Institute for Health Information. Physicians in Canada: The status of alternative payment programs. [Internet. Accessed February 20, 2014.] Available from: https://secure.cihi.ca/estore/productSeries.htm?pc=PCC47
30. Bernatsky S, Linehan T, Hanly JG. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol 2011;38:1612-6.
31. Robitaille C, Dai S, Waters C, Loukine L, Bancej C, Quach S, et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012;184:E49-56.
32. Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, et al. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia. Mult Scler 2012;18:1310-9.
33. Canadian Medical Association. Statistical information on Canadian physicians. 2009. [Internet. Accessed February 11, 2014.] Available from: www.cma.ca/index.cfm/ci-id/16959/la-id/1.htm
34. Barnabe C, Joseph L, Bélisle P, Labrecque J, Barr SG, Fritzler MJ, et al. Prevalence of autoimmune inflammatory myopathy in the first nations population of Alberta, Canada. Arthritis Care Res 2012;64:1715-9.
35. Barnabe C, Joseph L, Bélisle P, Labrecque J, Edworthy S, Barr SG, et al. Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care Res 2012;64:138-43.
36. Yiannakoulias N, Svenson LW, Schopflocher DP. An integrated framework for the geographic surveillance of chronic disease. Int J Health Geogr 2009;8:69.